 Connection
Rohit Katial to Adolescent
This is a "connection" page, showing publications Rohit Katial has written about Adolescent.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.291 |
|
|
|
-
Xu X, Kwiatek J, Siddall J, Genofre E, Stirnadel-Farrant H, Katial R. Patient-reported symptoms and burden of eosinophilic esophagitis: evidence from real-world clinical practice. BMC Gastroenterol. 2024 Aug 03; 24(1):246.
Score: 0.055
-
Katial JM, Hoyte FCL, Khatiwada A, Katial RK. Allergen skin test responses in broad U.S. asthma population in those with and without rhinitis. Allergy Asthma Proc. 2024 May 01; 45(3):158-165.
Score: 0.054
-
Fernández Pérez ER, Hunter M, Katial RK. United States trends in mortality rates for primary immunodeficiency diseases. J Allergy Clin Immunol Pract. 2019 Mar; 7(3):1045-1048.
Score: 0.037
-
Fountain CR, Mudd PA, Ramakrishnan VR, Sillau SH, Kingdom TT, Katial RK. Characterization and treatment of patients with chronic rhinosinusitis and nasal polyps. Ann Allergy Asthma Immunol. 2013 Nov; 111(5):337-41.
Score: 0.026
-
Katial RK, Bernstein D, Prazma CM, Lincourt WR, Stempel DA. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone. Allergy Asthma Proc. 2011 Mar-Apr; 32(2):127-36.
Score: 0.022
-
Wynne C, Lorch U, Krantz E, Katial R, Ashdown T, Luque M, Sattar A, Rai M, Vashishta L, Petrovic K, Ruffieux R, Leutz S, Berti F. Pharmacokinetic Similarity of Biosimiliar AVT05 Versus Reference Product Golimumab in Healthy Adults: A Double-Blind, Three-Arm, Parallel-Group Study. BioDrugs. 2026 Jan; 40(1):121-133.
Score: 0.015
-
Pavord I, Katial RK, Jackson DJ, Rogers L, Lega Hoyte FC, Smolen J, Wechsler ME, Akuthota P, Jackson DJ. Current data on biologics: Evaluating clinical remission in asthma. J Allergy Clin Immunol. 2025 Sep; 156(3S):S15-S19.
Score: 0.015
-
Waibel KH, Katial RK. Serum sickness-like reaction and bupropion. J Am Acad Child Adolesc Psychiatry. 2004 May; 43(5):509.
Score: 0.014
-
Brown LL, Patterson HS, Katial RK. A case of cyclical asthma exacerbations and associated left upper lobe collapse. Ann Allergy Asthma Immunol. 2002 Jan; 88(1):18-23.
Score: 0.012
-
Virchow JC, Katial R, Brusselle GG, Shalit Y, Garin M, McDonald M, Castro M. Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials. J Allergy Clin Immunol Pract. 2020 02; 8(2):540-548.e1.
Score: 0.010
-
Weinstein SF, Katial RK, Bardin P, Korn S, McDonald M, Garin M, Bateman ED, Hoyte FCL, Germinaro M. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract. 2019 02; 7(2):589-596.e3.
Score: 0.009
-
Katial RK, Stelzle RC, Bonner MW, Marino M, Cantilena LR, Smith LJ. A drug interaction between zafirlukast and theophylline. Arch Intern Med. 1998 Aug 10-24; 158(15):1713-5.
Score: 0.009
-
Busse WW, Katial R, Gossage D, Sari S, Wang B, Kolbeck R, Coyle AJ, Koike M, Spitalny GL, Kiener PA, Geba GP, Molfino NA. Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma. J Allergy Clin Immunol. 2010 Jun; 125(6):1237-1244.e2.
Score: 0.005
-
Murray JJ, Weiler JM, Schwartz LB, Busse WW, Katial RK, Lockey RF, McFadden ER, Pixton GC, Barrett RJ. Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma. Circ Cardiovasc Imaging. 2009 Nov; 2(6):492-8.
Score: 0.005
-
Silkoff PE, Carlson M, Bourke T, Katial R, Ogren E, Szefler SJ. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol. 2004 Nov; 114(5):1241-56.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|